Diabetic Neuropathic Pain Pathophysiology and Pain Management

  • Diana Christine Lalenoh Department of Anesthesiology & Intensive Therapy, Medical Faculty of Sam Ratulangi University, Prof. RD Kandou Hospital, Permata Bunda General Hospital, Manado-Indonesia.
  • Chilafat Dalimunte Department of Anesthesiology, SOS Freeport Hospital, Mitra Kemayoran Hospital, Jakarta-Indonesia.
Keywords: Diabetes Mellitus, Neuropathic Pain

Abstract

Background: Diabetes Mellitus (DM) is the most common cause of neuropathy in the Western world. There are 12,000,000 patients with non-insulin dependent DM (NIDDM) in the USA and 1,000,000 patients with insulin dependent DM (IDDM). At present 20% of people more than 65 years old have DM, by 2010 it will be more than 30%. Neuropathy occurs in NIDDM and IDDM, but may develop sooner after diagnosis in NIDDM. Medication selection should be individualized, considering side effects, potent beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary.

Downloads

Download data is not yet available.
Published
2016-12-15
How to Cite
Lalenoh, D. C., & Dalimunte, C. (2016). Diabetic Neuropathic Pain Pathophysiology and Pain Management. Academia Anesthesiologica International, 2(1), 21-24. https://doi.org/10.21276/aan.2017.2.1.6